An update on the first decade of the European centralized procedure: how many innovative drugs?

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: We recently proposed an algorithm to assess the degree of therapeutic innovation of new therapeutic agents. It was based on the disease seriousness, the availability of previous treatments and the extent of the therapeutic effect, and was applied to all ther...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Motola, Domenico, De Ponti, Fabrizio, Poluzzi, Elisabetta, Martini, Nello, Rossi, Pasqualino, Silvani, Maria Chiara, Vaccheri, Alberto, Montanaro, Nicola
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Blackwell Science Inc 2006
Θέματα:
Drug Development
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1885166/
https://ncbi.nlm.nih.gov/pubmed/16796703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2006.02700.x
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια